- Report
- May 2022
- 46 Pages
Global
From €2275EUR$2,500USD£1,951GBP
Endothelin 1 (ET-1) is a peptide hormone found in animals that plays a role in the regulation of blood pressure, inflammation, and other physiological processes. In the animal pharmaceuticals market, ET-1 is used to treat a variety of conditions, including pulmonary hypertension, congestive heart failure, and renal hypertension. It is also used to treat certain types of cancer, such as glioblastoma and melanoma. ET-1 is typically administered intravenously or subcutaneously, and is available in both injectable and oral formulations.
ET-1 is a relatively new drug, and its use in animal pharmaceuticals is still in its early stages. However, it has shown promise in treating a variety of conditions, and its use is expected to grow in the coming years.
Some companies in the ET-1 market include Pfizer, Merck, Novartis, and Eli Lilly. Show Less Read more